Market Overview:
Rising number of Blood Donation Campaigns Carried Out by Private and Government Organizations will help to boost global Disposable blood transfusion market in the forecasted period. Disposable Blood Transfusion includes various types such as Intravenous Needle, Blood Transfusion Bottle and Transfusion Catheters. Disposable blood bags is a term mainly related to storing, collection, transportation as well as transfusion of blood. Furthermore, disposable blood bags have significantly substituted glass bottles for the collection and storage of blood and its components, upsurge in demand for sterile processes of transportation and transfusion of blood and its components. These are the key driver of the global disposable transfusion market.
Attributes | Details |
---|
Study Period | 2018-2028 |
Base Year | 2022 |
High Growth Market | Asia- Pacific |
Unit | Value (USD Million) |
Key Companies Profiled | Fresenius SE & Co. KGaA (Germany), Terumo Corporation (Japan), Grifols, S.A (Spain), MacoPharma, S.A (France), HLL Lifecare Limited (India), Span Healthcare Private Limited (India), Haemonetics Corporation (United States), Neomedic International (Spain), B.Braun (Germany) and Helm Medical GmbH (Germany) |
CAGR | % |
Influencing Trend:
Increase in Blood Transfusion Procedures and Surge in Incidence of Trauma and Accidents around the Globe and Escalating Incidence of Various Blood-Related Diseases
Market Growth Drivers:
Rising Prevalence of Various Diseases and Surge in Awareness among People
Challenges:
Risks Related To Blood Transfusion Regulatory Factor
The key Players profiled in the report are Fresenius SE & Co. KGaA (Germany), Terumo Corporation (Japan), Grifols, S.A (Spain), MacoPharma, S.A (France), HLL Lifecare Limited (India), Span Healthcare Private Limited (India), Haemonetics Corporation (United States), Neomedic International (Spain), B.Braun (Germany) and Helm Medical GmbH (Germany). Additionally, other players that are of this comprehensive study are Poly Medicure Limited (France) and INNVOL Medical India Limited (India).
Market Development Activities
June 24, 2022 /PRNewswire/ -- Haemonetics Corporation (NYSE: HAE), a global medical technology company focused on delivering innovative medical solutions to drive better patient outcomes, today announced that it has fully commenced operations at its new manufacturing Center of Excellence in Clinton, PA. The custom-built facility occupies approximately 200,000 square feet at 1300 Clifford Ball Drive in Clinton Commerce Park near Pittsburgh International Airport.
Key Target Audience
Disposable Blood Transfusion Manufacturers, Disposable Blood Transfusion Distributors/Traders/Wholesalers, Disposable Blood Transfusion Subcomponent Manufacturers, Industry Association, Downstream Vendors, Medical Institutes, Government Regulatory Bodies, Government and Private Research Organizations and Others